Companies /Healthcare
Intuitive Surgical Inc
NASDAQ: ISRG Medical Instruments & Supplies
$442.07
▲ $5.20 (+1.19%) today
Markets open · 3:04pm ET

Intuitive Surgical (ISRG) Earnings History & Trends

EPS and revenue vs. Street estimates · SEC filings
ISRG vs Market · 30-day return after each reportISRGS&P 500
−7%0%+7%+14%+10.6%+8.2%Q1 25−5.1%+1.8%Q2 25+6.6%−1.3%Q3 25−3.4%+0.6%Q4 25−9.4%+4.8%Q1 26+13.3%+3.3%Q2 26
−7%0%+7%+14%Q1 25Q3 25Q1 26
ISRG EPS Trend · estimate vs actualEstimateActual
$0.00$0.90$1.80$2.70$1.73$1.81Q1 25$1.93$2.19Q2 25$1.99$2.40Q3 25$2.27$2.53Q4 25$2.11$2.50Q1 26$2.50$2.80Q2 26$2.64$3.00Q3 26
$0.00$0.90$1.80$2.70Q1 25Q3 25Q1 26Q3 26
ISRG Revenue Trend · estimate vs actualEstimateActual
$0$900.0M$1.8B$2.7B$2.2B$2.3BQ1 25$2.3B$2.4BQ2 25$2.4B$2.5BQ3 25$2.8B$2.9BQ4 25$2.6B$2.8BQ1 26$2.8B$2.9BQ2 26$2.9B$3.0BQ3 26
$0$900.0M$1.8B$2.7BQ1 25Q3 25Q1 26Q3 26

How Often Does Intuitive Surgical Beat Earnings Estimates?

Intuitive Surgical beat EPS estimates in 7 of its last 7 reported quarters, and has beaten 7 quarters in a row.

ISRG quarterly earnings per share and revenue versus Street estimates
Quarter EPS · est. Surprise Revenue · est. Surprise
Q3 2026 Non-GAAP EPS of $3.00 includes a $22 million after-tax ($0.06 per diluted share) benefit related to IEEPA tariff refunds for prior periods. GAAP EPS of $1.49 includes a $450 million pre-tax ($347 million after-tax, $0.99 per diluted share) litigation settlement charge. $3.00 est. $2.64 +13.61% $3.0B est. $2.9B +4.88%
Q2 2026 $2.80 est. $2.50 +11.83% $2.9B est. $2.8B +2.40%
Q1 2026 $2.50 est. $2.11 +18.66% $2.8B est. $2.6B +5.84%
Q4 2025 $2.53 est. $2.27 +11.51% $2.9B est. $2.8B +3.88%
Q3 2025 $2.40 est. $1.99 +20.65% $2.5B est. $2.4B +3.85%
Q2 2025 $2.19 est. $1.93 +13.22% $2.4B est. $2.3B +3.83%
Q1 2025 $1.81 est. $1.73 +4.41% $2.3B est. $2.2B +3.09%

Figures from SEC filings and company reports. Not investment advice.